About: Role of Incretin Axis in Inflammatory Bowel Disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Role of Incretin Axis in Inflammatory Bowel Disease Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Role of Incretin Axis in Inflammatory Bowel Disease
Creator	Zhong, Jixin Rao, Xiaoquan Braunstein, Zachary Duan, Lihua Toomey, Amelia Fang, Kai Sortino, Maria
Source	PMC
abstract	The inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract and involve a complicated reciprocity of environmental, genetic, and immunologic factors. Despite substantial advances in the foundational understanding of the immunological pathogenesis of IBD, the detailed mechanism of the pathological progression in IBD remains unknown. In addition to Th1/Th2 cells, whose role in IBD has been previously well defined, recent evidence indicates that Th17 cells and Tregs also play a crucial role in the development of IBD. Diets which contain excess sugars, salt, and fat may also be important actors in the pathogenesis of IBD, which may be the cause of high IBD incidence in western developed and industrialized countries. Up until now, the reason for the variance in prevalence of IBD between developed and developing countries has been unknown. This is partly due to the increasing popularity of western diets in developing countries, which makes the data harder to interpret. The enterocrinins glucagon-like peptides (GLPs), including GLP-1 and GLP-2, exhibit notable benefits on lipid metabolism, atherosclerosis formation, plasma glucose levels, and maintenance of gastric mucosa integrity. In addition to the regulation of nutrient metabolism, the emerging role of GLPs and their degrading enzyme dipeptidyl peptidase-4 (DPP-4) in gastrointestinal diseases has gained increasing attention. Therefore, here we review the function of the DPP-4/GLP axis in IBD.
has issue date	2017-12-06(xsd:dateTime)
bibo:doi	10.3389/fimmu.2017.01734
bibo:pmid	29270177
has license	cc-by
sha1sum (hex)	7fd0d03264447b79984a3a48e12470e08df672d0
schema:url	https://doi.org/10.3389/fimmu.2017.01734
resource representing a document's title	Role of Incretin Axis in Inflammatory Bowel Disease
has PubMed Central identifier	PMC5723660
has PubMed identifier	29270177
schema:publication	Front Immunol
resource representing a document's body	covid:7fd0d03264447b79984a3a48e12470e08df672d0#body_text
is schema:about of	named entity 'detailed' named entity 'function' named entity 'complicated' named entity 'cells' named entity 'evidence' named entity 'GASTRIC MUCOSA' named entity 'CONDITIONS' named entity 'METABOLISM' named entity 'COMPLICATED' named entity 'PLAY' named entity 'CONTAIN' named entity 'MAINTENANCE' named entity 'WELL DEFINED' named entity 'PATHOLOGICAL' named entity 'CAUSE' named entity 'AXIS' named entity 'GLP-2' named entity 'DIETS' named entity 'PREVALENCE' named entity 'EXHIBIT' named entity 'IMMUNOLOGICAL' named entity 'LIPID METABOLISM' named entity 'INCIDENCE' named entity 'DISEASE' named entity 'PLASMA GLUCOSE' named entity 'SUGARS' named entity 'GAINED' named entity 'MAY BE' named entity 'REVIEW' named entity 'CROHN' named entity 'FUNCTION' named entity 'ACTORS' named entity 'ATTENTION' named entity 'IMMUNOLOGIC FACTORS' named entity 'PREVIOUSLY' named entity 'MECHANISM' named entity 'WESTERN' named entity 'GLP-1' named entity 'UNDERSTANDING' named entity 'COUNTRIES' named entity 'DUE TO' named entity 'INFLAMMATORY BOWEL DISEASES' named entity 'ENZYME' named entity 'JOURNAL ' named entity 'GLUCAGON-LIKE PEPTIDES' named entity 'NOTABLE' named entity 'RECIPROCITY' named entity '27S' named entity 'DEVELOPING COUNTRIES' named entity 'ULCERATIVE COLITIS' named entity 'DEVELOPMENT' named entity 'UNKNOWN' named entity 'ATHEROSCLEROSIS' named entity 'ADDITION' named entity 'IMPORTANT' named entity 'ROLE' named entity 'INCRETIN' named entity 'INFLAMMATORY BOWEL DISEASE' named entity 'AXIS' named entity 'IBD' named entity 'PATHOGENESIS' named entity 'IMMUNOLOGY' named entity 'GLUCOSE LEVELS' named entity 'EVIDENCE' named entity 'INCREASING' named entity 'BENEFITS' named entity 'TH1' named entity 'SALT' named entity 'INCLUDING' named entity 'ENVIRONMENTAL' named entity 'DIPEPTIDYL PEPTIDASE' named entity 'DATA' named entity 'FAT' named entity 'PROGRESSION' named entity 'TH17 CELLS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software